 |
 |

Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill—Invited Commentary
Sumit R. Majumdar, MD, MPH, FRCPC
Arch Intern Med. 2009;169(8):748-749.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Cost-related nonadherence (CRN) is common, and one-third of older adults take less medication than prescribed to reduce out-of-pocket costs.1 Common strategies to reduce out-of-pocket costs include splitting pills, skipping doses, or delaying refills, all secondary forms of nonadherence.1 Less attention has been paid to "primary" nonadherence, ie, not even filling the prescription. This strategy is the most effective way to reduce out-of-pocket costs, and primary nonadherence is practiced by 10% to 20% of patients.2
Short of a randomized trial, the best way to understand the effect of out-of-pocket costs on primary or secondary nonadherence would be to undertake a large longitudinal study of older insured patients who are "exposed" to drug benefit plans of differing generosities and who go on to develop an incident diagnosis of a chronic condition that requires new treatment and then to measure the receipt of a prescription (under control . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill
Matthew D. Solomon, Dana P. Goldman, Geoffrey F. Joyce, and José J. Escarce
Arch Intern Med. 2009;169(8):740-748.
ABSTRACT
| FULL TEXT
|